Indication
Hypobetalipoproteinemia
1 clinical trial
1 product
Clinical trial
HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol MetabolismStatus: Active (not recruiting), Estimated PCD: 2022-01-07
1 clinical trial
1 product